Document Classification

Section Type: RESULTS

Text: Fewer cases (p < 0. 0001) of severe rotavirus gastroenteritis were recorded for the combined 2-year period in the RIX4414 group (32 [0. 4 %] of 7205 ; 95 % CI 0. 3-0. 6) than in the placebo group (161 [2. 3 %] of 7081 ; 1. 9-2. 6), resulting in a vaccine efficacy of 80. 5 % (71. 3-87. 1) to 82. 1 % (64. 6-91. 9) against wild-type G1, 77. 5 % (64. 7-86. 2) against pooled non-G1 strains, and 80. 5 % (67. 9-88. 8) against pooled non-G1 P [8] strains.